Mark Kriegsmann

6.0k citations

181 papers · 3.0k indexed · h-index 32

Impact in

Spectroscopy top 1%
- Mass Spectrometry Techniques and Applications
- Advanced Proteomics Techniques and Applications
Cancer Research top 5%
- Cancer Genomics and Diagnostics

Papers in ⓘ

Cancer Research 37
- Cancer Genomics and Diagnostics 21
Oncology 67
- Lung Cancer Research Studies 16

Co-authors: Jörg Kriegsmann (38 shared papers)Rita Casadonte (40 shared papers)Katharina Kriegsmann (79 shared papers)Wilko Weichert (31 shared papers)Rémi Longuespée (28 shared papers)Albrecht Stenzinger (34 shared papers)Thomas Muley (41 shared papers)Arne Warth (25 shared papers)
Journals: Cancers (16 papers)PROTEOMICS - CLINICAL APPLICATIONS (14 papers)International Journal of Molecular Sciences (6 papers)European Journal Of Haematology (6 papers)Frontiers in Oncology (6 papers)
Partner nations: Germany United States Austria

In The Last Decade

Mark Kriegsmann

170 papers receiving 3.0k citations

Peers

Countries citing papers authored by Mark Kriegsmann

Since Specialization

Citations

This map shows the geographic impact of Mark Kriegsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kriegsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kriegsmann more than expected).

Fields of papers citing papers by Mark Kriegsmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kriegsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kriegsmann. The network helps show where Mark Kriegsmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Kriegsmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Kriegsmann Line = papers co-authored together Mark Kriegsmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MALDI TOF imaging mass spectrometry in clinical pathology: A valuable tool for cancer diagnostics (Review) International Journal of Oncology ·Jörg Kriegsmann, Mark Kriegsmann, Rita Casadonte	2014	127
2	Uncoupling Malt1 Threshold Function from Paracaspase Activity Results in Destructive Autoimmune Inflammation Cell Reports ·Andreas Gewies, Oliver Gorka, Hanna Bergmann, Konstanze Pechloff, Franziska Petermann, Katharina M. Jeltsch, Martina Rudelius, Mark Kriegsmann, Wilko Weichert, Marion Horsch, Johannes Beckers, Wolfgang Wurst, Mathias Heikenwälder, Thomas Korn, Vigo Heissmeyer, Jürgen Ruland	2014	115
3	Effect of Increased Lactate Dehydrogenase A Activity and Aerobic Glycolysis on the Proinflammatory Profile of Autoimmune CD8+ T Cells in Rheumatoid Arthritis Arthritis & Rheumatology ·Margarida Souto‐Carneiro, Karel D. Klika, Mónica Abreu, André P. Meyer, Rainer Saffrich, Roger Sandhoff, Richard Jennemann, Franziska V. Kraus, Lars‐Oliver Tykocinski, Volker Eckstein, Lina Carvalho, Mark Kriegsmann, Thomas Giese, Hanns‐Martin Lorenz, Rui A. Carvalho	2020	79
4	Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens Molecular & Cellular Proteomics ·Mark Kriegsmann, Rita Casadonte, Jörg Kriegsmann, Hendrik Dienemann, Peter Schirmacher, Jan Hendrik Kobarg, Kristina Schwamborn, Albrecht Stenzinger, Arne Warth, Wilko Weichert	2016	76
5	A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing Methods ·Rémi Longuespée, Deborah Alberts, Charles Pottier, Nicolas Smargiasso, Gabriel Mazzucchelli, Dominique Baiwir, Mark Kriegsmann, Michaël Herfs, Jörg Kriegsmann, Philippe Delvenne, Edwin De Pauw	2015	69
6	Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples PROTEOMICS - CLINICAL APPLICATIONS ·Alice Ly, Rémi Longuespée, Rita Casadonte, Petra Wandernoth, Kristina Schwamborn, Christine Bollwein, Christian Marsching, Katharina Kriegsmann, Carsten Hopf, Wilko Weichert, Jörg Kriegsmann, Peter Schirmacher, Mark Kriegsmann, Sören‐Oliver Deininger	2018	67
7	Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin‐fixed paraffin‐embedded tissues PROTEOMICS ·Rita Casadonte, Mark Kriegsmann, Friederike Zweynert, Katrin Friedrich, Gustavo Bretton, Mike Otto, Sören‐Oliver Deininger, Rainer Paape, Eckhard Belau, Detlev Suckau, Daniela E. Aust, Christian Pilarsky, Jörg Kriegsmann	2014	63
8	Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience Lung Cancer ·Florian Eichhorn, Laura V. Klotz, Mark Kriegsmann, Helge Bischoff, Marc A. Schneider, Thomas Muley, Katharina Kriegsmann, Uwe Haberkorn, Claus Peter Heußel, Rajkumar Savai, Inka Zoernig, Dirk Jaeger, Michael Thomas, Hans Hoffmann, H. Winter, Martin Eichhorn	2021	61
9	MALDI mass spectrometry imaging: A cutting‐edge tool for fundamental and clinical histopathology PROTEOMICS - CLINICAL APPLICATIONS ·Rémi Longuespée, Rita Casadonte, Mark Kriegsmann, Charles Pottier, Gaël Picard de Muller, Philippe Delvenne, Jörg Kriegsmann, Edwin De Pauw	2016	61
10	Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells Nature Communications ·Marc Rosenbaum, Andreas Gewies, Konstanze Pechloff, Christoph Heuser, Thomas Engleitner, Torben Gehring, Lara Hartjes, S. Krebs, Daniel Krappmann, Mark Kriegsmann, Wilko Weichert, Roland Rad, Christian Kurts, Jürgen Ruland	2019	60
11	Increases in Tumor N‐Glycan Polylactosamines Associated with Advanced HER2‐Positive and Triple‐Negative Breast Cancer Tissues PROTEOMICS - CLINICAL APPLICATIONS ·Danielle A. Scott, Rita Casadonte, Bárbara Cardinali, Laura Spruill, Anand S. Mehta, Franca Carli, Nicole L. Simone, Mark Kriegsmann, Lucia Del Mastro, Joerg Kriegsmann, Richard R. Drake	2018	57
12	MALDI imaging mass spectrometry — From bench to bedside Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Kristina Schwamborn, Mark Kriegsmann, Wilko Weichert	2016	54
13	Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study BMC Cancer ·Cina J. Nattenmüller, Mark Kriegsmann, Disorn Sookthai, Renée T. Fortner, Annika Steffen, Britta Walter, Theron Johnson, Jutta Kneisel, Verena Katzke, Manuela M. Bergmann, Hans‐Peter Sinn, Peter Schirmacher, Esther Herpel, Heiner Boeing, Rudolf Kaaks, Tilman Kühn	2018	53
14	Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors Cancers ·Stephan Rheinheimer, Claus Peter Heußel, Philipp Mayer, Lena Gaissmaier, Farastuk Bozorgmehr, H. Winter, Felix Herth, Thomas Muley, Stephan Liersch, Helge Bischoff, Mark Kriegsmann, Rami A. El Shafie, Albrecht Stenzinger, Michael Thomas, Hans‐Ulrich Kauczor, Petros Christopoulos	2020	52
15	Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences Oncotarget ·Mark Kriegsmann, Volker Endris, Thomas Wolf, Nicole Pfarr, Albrecht Stenzinger, Sibylle Loibl, Carsten Denkert, Andreas Schneeweiß, Jan Budczies, Hans‐Peter Sinn, Wilko Weichert	2014	51
16	Deep Learning for the Classification of Non-Hodgkin Lymphoma on Histopathological Images Cancers ·Georg Steinbuß, Mark Kriegsmann, Christiane Zgorzelski, Alexander Brobeil, Benjamin Goeppert, Sascha Dietrich, Gunhild Mechtersheimer, Katharina Kriegsmann	2021	45
17	Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast—implications for tumor biology and pathological diagnosis Genes Chromosomes and Cancer ·Nicole Pfarr, Mark Kriegsmann, Hans‐Peter Sinn, Frederick Klauschen, Volker Endris, Esther Herpel, Alexander Muckenhuber, Moritz Jesinghaus, B. Klosterhalfen, Roland Penzel, Jochen K. Lennerz, Wilko Weichert, Albrecht Stenzinger	2015	44
18	A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma OncoImmunology ·Jan Budczies, Martina Kirchner, Klaus Kluck, Daniel Kazdal, Julia Glade, Michael Allgäuer, Mark Kriegsmann, Claus Peter Heußel, Felix Herth, H. Winter, Michael Meister, Thomas Muley, Stefan Fröhling, Solange Peters, Barbara Seliger, Peter Schirmacher, Michael Thomas, Petros Christopoulos, Albrecht Stenzinger	2021	43
19	Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer Frontiers in Oncology ·Lea Daniello, Mariam Elshiaty, Farastuk Bozorgmehr, Jonas Kuon, Daniel Kazdal, Hannah Schindler, Rajiv Shah, Anna‐Lena Volckmar, Fabienne Lusky, L. Diekmann, Stephan Liersch, Martin Faehling, Thomas Muley, Mark Kriegsmann, Karolina Benesova, Albrecht Stenzinger, Michael Thomas, Petros Christopoulos	2021	42
20	Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases Diagnostic Pathology ·Mark Kriegsmann, Thomas Muley, Alexander Harms, Luca Tavernar, Torsten Goldmann, Hendrik Dienemann, Esther Herpel, Arne Warth	2015	42

About Mark Kriegsmann

Mark Kriegsmann is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Spectroscopy and Hematology, having authored 181 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Advanced Proteomics Techniques and Applications (26 papers), Mass Spectrometry Techniques and Applications (25 papers), Molecular Biology Techniques and Applications (22 papers), Cancer Genomics and Diagnostics (21 papers), Lung Cancer Research Studies (16 papers), Lung Cancer Diagnosis and Treatment (16 papers) and Medical Imaging and Pathology Studies (10 papers). The work is most often cited by research in Spectroscopy (779 citations), Cancer Research (529 citations), Oncology (938 citations), Molecular Biology (1.3k citations) and Immunology (360 citations). Mark Kriegsmann has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Jörg Kriegsmann, Rita Casadonte, Katharina Kriegsmann, Wilko Weichert, Rémi Longuespée, Albrecht Stenzinger, Thomas Muley, Arne Warth, Kristina Schwamborn and Daniel Kazdal. Their work appears in journals such as Cancers, PROTEOMICS - CLINICAL APPLICATIONS, International Journal of Molecular Sciences, European Journal Of Haematology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact